Detalles de la búsqueda
1.
Benralizumab in Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps: The Real-World, Multi-Country RANS Observational Study.
J Asthma Allergy;
17: 313-324, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38595692
2.
Clinical Implications of Longitudinal Blood Eosinophil Counts in Patients With Severe Asthma.
J Allergy Clin Immunol Pract;
11(6): 1805-1813, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868471
3.
Real-World Investigation of Eosinophilic-Associated Disease Overlap (REVEAL): Analysis of a US Claims Database.
Allergy Asthma Immunol Res;
15(5): 580-602, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37827978
4.
Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: A retrospective analysis of US health insurance claims data.
JAAD Int;
13: 117-125, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37808963
5.
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
J Allergy Clin Immunol Pract;
11(6): 1759-1770.e7, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948488
6.
COMMENT ON MODEL INPUTS AND ASSUMPTIONS FOR THE COST-MINIMIZATION MODEL USED TO COMPARE COST OF BIOLOGICS IN SEVERE ASTHMA.
J Manag Care Spec Pharm;
30(4): 397-398, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555627
Resultados
1 -
6
de 6
1
Próxima >
>>